Stereotactic ablative radiotherapy (SABR) is mostly used for the treatment of small numbers of kidney cancer metastases in the brain. This review of the literature looked at the use of SABR as a potential treatment option for small numbers of kidney cancer metastases in other organs and tissues.
The use of SABR for the treatment of small numbers of metastases can control the cancer for long periods of time and can be used to supplement medical treatment and improve overall survival.
This study highlighted the benefit of SABR for the treatment of kidney cancer metastases in different organs and tissues. More research is needed to clarify the role of SABR and its effects to boost the immune system.